Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Intracellular Vitamin D to Combat Instant Blood-Mediated Inflammatory Reaction

Award Number: R03AI185599
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 07/10/2024
PERIOD OF PERFORMANCE END DATE: 05/31/2027

Group Awards By:

View Award Description

Intracellular Vitamin D to Combat Instant Blood-Mediated Inflammatory Reaction - PROJECT/SUMMARY ABSTRACT The objective of this proposal is to assess a nanotherapeutic for the treatment of islet transplantation associated instant-blood-mediated inflammatory reaction (IBMIR). Islet transplantation is a promising treatment for patients with type 1 diabetes and late-stage chronic pancreatitis. Isolated islets are infused into the patient’s liver in a minimally invasive manner via the portal vein. The goal of this procedure is to restore normoglycemia. Unfortunately, the IBMIR occurs when the islets contact blood and activate oxidative, inflammatory, and coagulation pathways. The cumulative oxidative thrombo-inflammatory stress causes islet necrosis and apoptosis. As a result, 50-70% of the transplanted islets are lost within the first 24 hours following infusion, making achieving insulin independence extremely difficult. Previous strategies to combat IBMIR include the use of anti-thrombotic drugs, such as heparin, which increases bleeding risk, or low molecular weight dextran sulfate, which prevents cell aggregation, but fails to combat inflammation and cytokine secretion that ultimately kills the islets or requires islet surface modification that complicates cell processing. There is a need for a therapeutic that combats oxidation, inflammation, and thrombosis associated with IBMIR without inducing bleeding. Vitamin D (aVD; 1, 25-Dihydroxyvitamin D3) is a potent activator of nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant activity and a powerful inhibitor of nuclear factor kappa B (NF-κB)-dependent inflammation and coagulation. aVD acts via interaction with the intracellular vitamin D receptor (VDR). However, VDR interaction can be limited, as hydrophobic aVD has poor bioavailability and membrane permeability, both of which limit therapeutic efficacy. Targeted aVD delivery is further complicated by the ubiquitous nature of VDR, which is present in almost every cell. The highly cell-type specific results of aVD-VDR interaction can cause adverse effects, including toxicity if the wrong cell population is treated. Vesicular polymeric nanocarriers (i.e. polymersomes, PS) encapsulating vitamin D3 (aVD-PS) were found to enhance intracellular delivery of aVD within antigen-presenting cells, reducing inflammatory markers, including CD80/86 and MHC II. PS can be infused with the islets or targeted to the site of transplantation (the liver) via intravenous injection. Here, this proposal will investigate aVD-PS’s biocompatibility with and ability to combat oxidative thrombo-inflammation associated with IBMIR for the preservation of islets. The mechanisms by which aVD-PS mitigates oxidative stress, thrombosis and inflammation will also be assessed. The following aims will be achieved: 1) Assess the biocompatibility of aVD-PS with human islets and the effect of aVD-PS on coagulation under IBMIR conditions. 2) Assess the ability of aVD-PS to mitigate IBMIR in a murine islet transplantation model.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $0 )
2026	2025	NORTHWESTERN UNIVERSITY	633 CLARK ST	EVANSTON	IL	60208	COOK	USA	Allergy and Infectious Diseases Research	000	2	3/6/2026	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2025 ( Subtotal = $80,000 )
2025	2025	NORTHWESTERN UNIVERSITY	633 CLARK ST	EVANSTON	IL	60208	COOK	USA	Allergy and Infectious Diseases Research	000	2	8/11/2025	NON-COMPETING CONTINUATION	$80,000
														Subtotal = $80,000

Issue Date FY: 2024 ( Subtotal = $80,000 )
2024	2024	NORTHWESTERN UNIVERSITY	633 CLARK ST	EVANSTON	IL	60208	COOK	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$8,000
2024	2024	NORTHWESTERN UNIVERSITY	633 CLARK ST	EVANSTON	IL	60208	COOK	USA	Allergy and Infectious Diseases Research	000	1	7/10/2024	NEW	$72,000
														Subtotal = $80,000

Grand Total All Awards = $160,000

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Intracellular Vitamin D to Combat Instant Blood-Mediated Inflammatory Reaction

Award Number: R03AI185599

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 07/10/2024

PERIOD OF PERFORMANCE END DATE: 05/31/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer